1. 121. Consistent long term efficacy and safety of repeat onabotulinumtoxinA injections in patients with neurogenic detrusor overactivity: final results of up to 4 years' treatment. (January 2015) Authors: Kennelly, Michael; Dmochowski, Roger; Ethans, Karen; Moore, Courtenay; Schulte-Baukloh, Heinrich; Jenkins, Brenda; Guard, Steven; Zheng, Yan; Karsenty, Gilles Journal: Toxicon Issue: Volume 93(2015)Supplement Page Start: S37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 150. Long-term efficacy and safety of onabotulinumtoxinA treatment in overactive bladder syndrome and urinary incontinence: interim analysis with median 2.4 years' follow-up. (January 2015) Authors: Nitti, Victor; Chapple, Christopher; Sussman, David; Radomski, Sidney; Sand, Peter; Jenkins, Brenda; Zhou, Jihao; Sievert, Karl-Dietrich Journal: Toxicon Issue: Volume 93(2015)Supplement Page Start: S46 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy and safety of onabotulinumtoxina 100 U for treatment of urinary incontinence due to neurogenic detrusor overactivity in noncatheterizing multiple sclerosis patients. (25th December 2016) Authors: Cruz, Francisco; Denys, Pierre; Keppenne, Veronique; Kohan, Alfred; Brucker, Benjamin; Egerdie, Blair; Magyar, Andrew; Nicandro, J.P.; Jenkins, Brenda; Chartier-Kastler, Emmanuel Journal: Toxicon Issue: Volume 123(2016) Supplement Page Start: S19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Efficacy and safety of onabotulinumtoxinA therapy are sustained over 4 years of treatment in patients with neurogenic detrusor overactivity: Final results of a long‐term extension study. Issue 2 (24th November 2015) Authors: Kennelly, Michael; Dmochowski, Roger; Schulte‐Baukloh, Heinrich; Ethans, Karen; Del Popolo, Giulio; Moore, Courtenay; Jenkins, Brenda; Guard, Steven; Zheng, Yan; Karsenty, Gilles Journal: Neurourology and urodynamics Issue: Volume 36:Issue 2(2017:Feb.) Page Start: 368 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Efficacy and safety of three active doses of onabotulinumtoxinA for the treatment of neurogenic detrusor overactivity in children: Results of a randomized controlled clinical trial. (January 2021) Authors: Austin, Paul F.; Franco, Israel; Dobremez, Eric; Kroll, Pawel; Titanji, Wilson; Geib, Till; Jenkins, Brenda; Hoebeke, Piet B. Journal: Toxicon Issue: Volume 190(2021)supplement 1 Page Start: S6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Intravesical Instillation of OnabotulinumtoxinA in the Treatment of Refractory Overactive Bladder in Participants with Urinary Incontinence. Issue 4 (5th October 2022) Authors: Chermansky, Christopher J.; Richter, Holly E.; Jacoby, Karny; Titanji, Wilson; Jenkins, Brenda; Geib, Till; Brucker, Benjamin M. Journal: Journal of urology Issue: Volume 208:Issue 4(2022) Page Start: 855 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Long-Term Safety and Tolerability of Repeated Treatments With OnabotulinumtoxinA in Children with Neurogenic Detrusor Overactivity. (July 2022) Authors: Franco, Israel; Dobremez, Eric; Hoebeke, Piet B.; Titanji, Wilson; Yushmanova, Irina; Jenkins, Brenda; Austin, Paul F. Journal: Toxicon Issue: Volume 214(2022)Supplement 1 Page Start: S18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Long-term Safety and Tolerability of Repeated Treatments With OnabotulinumtoxinA in Children With Neurogenic Detrusor Overactivity. Issue 4 (19th April 2023) Authors: Franco, Israel; Hoebeke, Piet B.; Dobremez, Eric; Titanji, Wilson; Geib, Till; Jenkins, Brenda; Yushmanova, Irina; Austin, Paul F. Journal: Journal of urology Issue: Volume 209:Issue 4(2023) Page Start: 774 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Low-dose onabotulinumtoxinA improves urinary symptoms in noncatheterizing patients with MS. (14th August 2018) Authors: Tullman, Mark; Chartier-Kastler, Emmanuel; Kohan, Alfred; Keppenne, Veronique; Brucker, Benjamin M.; Egerdie, Blair; Mandle, Meryl; Nicandro, Jean Paul; Jenkins, Brenda; Denys, Pierre Journal: Neurology Issue: Volume 91:Number 7(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. OnabotulinumtoxinA for the treatment of neurogenic detrusor overactivity in children. Issue 1 (11th December 2020) Authors: Austin, Paul F.; Franco, Israel; Dobremez, Eric; Kroll, Pawel; Titanji, Wilson; Geib, Till; Jenkins, Brenda; Hoebeke, Piet B. Journal: Neurourology and urodynamics Issue: Volume 40:Issue 1(2021) Page Start: 493 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗